0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Pruritus Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: March 2024
|
Report Code: QYRE-Auto-11U11110
Home | Market Reports | Health| Health Conditions| Skin Conditions
Global Pruritus Therapeutics Sales Market Report 2022
BUY CHAPTERS

Pruritus Therapeutics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-11U11110
Report
March 2024
Pages:109
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pruritus Therapeutics - Market Size

The global market for Pruritus Therapeutics was estimated to be worth US$ 13680 million in 2023 and is forecast to a readjusted size of US$ 18060 million by 2030 with a CAGR of 4.0% during the forecast period 2024-2030

Pruritus Therapeutics - Market

Pruritus Therapeutics - Market

Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pruritus Therapeutics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Pruritus Therapeutics by region & country, by Type, and by Application.
The Pruritus Therapeutics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pruritus Therapeutics.
Market Segmentation

Scope of Pruritus Therapeutics - Market Report

Report Metric Details
Report Name Pruritus Therapeutics - Market
Forecasted market size in 2030 US$ 18060 million
CAGR 4.0%
Forecasted years 2024 - 2030
Segment by Type:
  • Antihistamines
  • Corticosteroids
  • Calcineurin Inhibitors
  • Others
Segment by Application
  • External Use
  • Oral
  • Injection
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Pruritus Therapeutics manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Pruritus Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Pruritus Therapeutics in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Pruritus Therapeutics - Market size in 2030?

Ans: The Pruritus Therapeutics - Market size in 2030 will be US$ 18060 million.

What is the J&J, Abbott, Amgen, LEO Pharma share in Pruritus Therapeutics - Market?

Ans: J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.

What is the Pruritus Therapeutics - Market share by region?

Ans: North America is the largest consumption place, with a revenue market share nearly 43%.

Who are the main players in the Pruritus Therapeutics - Market report?

Ans: The main players in the Pruritus Therapeutics - Market are J&J, Abbott, Amgen, LEO Pharma, Novartis, Bayer, Pfizer, UCB Pharma, GlaxoSmithKline, Galderma, Huapont

What are the Application segmentation covered in the Pruritus Therapeutics - Market report?

Ans: The Applications covered in the Pruritus Therapeutics - Market report are External Use, Oral, Injection

What are the Type segmentation covered in the Pruritus Therapeutics - Market report?

Ans: The Types covered in the Pruritus Therapeutics - Market report are Antihistamines, Corticosteroids, Calcineurin Inhibitors, Others

1 Market Overview
1.1 Pruritus Therapeutics Product Introduction
1.2 Global Pruritus Therapeutics Market Size Forecast
1.3 Pruritus Therapeutics Market Trends & Drivers
1.3.1 Pruritus Therapeutics Industry Trends
1.3.2 Pruritus Therapeutics Market Drivers & Opportunity
1.3.3 Pruritus Therapeutics Market Challenges
1.3.4 Pruritus Therapeutics Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pruritus Therapeutics Players Revenue Ranking (2023)
2.2 Global Pruritus Therapeutics Revenue by Company (2019-2024)
2.3 Key Companies Pruritus Therapeutics Manufacturing Base Distribution and Headquarters
2.4 Key Companies Pruritus Therapeutics Product Offered
2.5 Key Companies Time to Begin Mass Production of Pruritus Therapeutics
2.6 Pruritus Therapeutics Market Competitive Analysis
2.6.1 Pruritus Therapeutics Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Pruritus Therapeutics Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antihistamines
3.1.2 Corticosteroids
3.1.3 Calcineurin Inhibitors
3.1.4 Others
3.2 Global Pruritus Therapeutics Sales Value by Type
3.2.1 Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pruritus Therapeutics Sales Value, by Type (2019-2030)
3.2.3 Global Pruritus Therapeutics Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 External Use
4.1.2 Oral
4.1.3 Injection
4.2 Global Pruritus Therapeutics Sales Value by Application
4.2.1 Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pruritus Therapeutics Sales Value, by Application (2019-2030)
4.2.3 Global Pruritus Therapeutics Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Pruritus Therapeutics Sales Value by Region
5.1.1 Global Pruritus Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pruritus Therapeutics Sales Value by Region (2019-2024)
5.1.3 Global Pruritus Therapeutics Sales Value by Region (2025-2030)
5.1.4 Global Pruritus Therapeutics Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Pruritus Therapeutics Sales Value, 2019-2030
5.2.2 North America Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Pruritus Therapeutics Sales Value, 2019-2030
5.3.2 Europe Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Pruritus Therapeutics Sales Value, 2019-2030
5.4.2 Asia Pacific Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Pruritus Therapeutics Sales Value, 2019-2030
5.5.2 South America Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Pruritus Therapeutics Sales Value, 2019-2030
5.6.2 Middle East & Africa Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pruritus Therapeutics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pruritus Therapeutics Sales Value
6.3 United States
6.3.1 United States Pruritus Therapeutics Sales Value, 2019-2030
6.3.2 United States Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pruritus Therapeutics Sales Value, 2019-2030
6.4.2 Europe Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pruritus Therapeutics Sales Value, 2019-2030
6.5.2 China Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pruritus Therapeutics Sales Value, 2019-2030
6.6.2 Japan Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pruritus Therapeutics Sales Value, 2019-2030
6.7.2 South Korea Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pruritus Therapeutics Sales Value, 2019-2030
6.8.2 Southeast Asia Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pruritus Therapeutics Sales Value, 2019-2030
6.9.2 India Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pruritus Therapeutics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 J&J
7.1.1 J&J Profile
7.1.2 J&J Main Business
7.1.3 J&J Pruritus Therapeutics Products, Services and Solutions
7.1.4 J&J Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.1.5 J&J Recent Developments
7.2 Abbott
7.2.1 Abbott Profile
7.2.2 Abbott Main Business
7.2.3 Abbott Pruritus Therapeutics Products, Services and Solutions
7.2.4 Abbott Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.2.5 Abbott Recent Developments
7.3 Amgen
7.3.1 Amgen Profile
7.3.2 Amgen Main Business
7.3.3 Amgen Pruritus Therapeutics Products, Services and Solutions
7.3.4 Amgen Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.3.5 LEO Pharma Recent Developments
7.4 LEO Pharma
7.4.1 LEO Pharma Profile
7.4.2 LEO Pharma Main Business
7.4.3 LEO Pharma Pruritus Therapeutics Products, Services and Solutions
7.4.4 LEO Pharma Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.4.5 LEO Pharma Recent Developments
7.5 Novartis
7.5.1 Novartis Profile
7.5.2 Novartis Main Business
7.5.3 Novartis Pruritus Therapeutics Products, Services and Solutions
7.5.4 Novartis Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.5.5 Novartis Recent Developments
7.6 Bayer
7.6.1 Bayer Profile
7.6.2 Bayer Main Business
7.6.3 Bayer Pruritus Therapeutics Products, Services and Solutions
7.6.4 Bayer Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.6.5 Bayer Recent Developments
7.7 Pfizer
7.7.1 Pfizer Profile
7.7.2 Pfizer Main Business
7.7.3 Pfizer Pruritus Therapeutics Products, Services and Solutions
7.7.4 Pfizer Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.7.5 Pfizer Recent Developments
7.8 UCB Pharma
7.8.1 UCB Pharma Profile
7.8.2 UCB Pharma Main Business
7.8.3 UCB Pharma Pruritus Therapeutics Products, Services and Solutions
7.8.4 UCB Pharma Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.8.5 UCB Pharma Recent Developments
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Profile
7.9.2 GlaxoSmithKline Main Business
7.9.3 GlaxoSmithKline Pruritus Therapeutics Products, Services and Solutions
7.9.4 GlaxoSmithKline Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.9.5 GlaxoSmithKline Recent Developments
7.10 Galderma
7.10.1 Galderma Profile
7.10.2 Galderma Main Business
7.10.3 Galderma Pruritus Therapeutics Products, Services and Solutions
7.10.4 Galderma Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.10.5 Galderma Recent Developments
7.11 Huapont
7.11.1 Huapont Profile
7.11.2 Huapont Main Business
7.11.3 Huapont Pruritus Therapeutics Products, Services and Solutions
7.11.4 Huapont Pruritus Therapeutics Revenue (US$ Million) & (2019-2024)
7.11.5 Huapont Recent Developments
8 Industry Chain Analysis
8.1 Pruritus Therapeutics Industrial Chain
8.2 Pruritus Therapeutics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pruritus Therapeutics Sales Model
8.5.2 Sales Channel
8.5.3 Pruritus Therapeutics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Pruritus Therapeutics Market Trends
    Table 2. Pruritus Therapeutics Market Drivers & Opportunity
    Table 3. Pruritus Therapeutics Market Challenges
    Table 4. Pruritus Therapeutics Market Restraints
    Table 5. Global Pruritus Therapeutics Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Pruritus Therapeutics Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Pruritus Therapeutics Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Pruritus Therapeutics Product Type
    Table 9. Key Companies Time to Begin Mass Production of Pruritus Therapeutics
    Table 10. Global Pruritus Therapeutics Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Pruritus Therapeutics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Pruritus Therapeutics Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Pruritus Therapeutics Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Pruritus Therapeutics Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Pruritus Therapeutics Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Pruritus Therapeutics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Pruritus Therapeutics Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Pruritus Therapeutics Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Pruritus Therapeutics Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Pruritus Therapeutics Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Pruritus Therapeutics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Pruritus Therapeutics Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Pruritus Therapeutics Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Pruritus Therapeutics Sales Value by Region (2019-2024) & (%)
    Table 27. Global Pruritus Therapeutics Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Pruritus Therapeutics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Pruritus Therapeutics Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Pruritus Therapeutics Sales Value, (2025-2030) & (US$ Million)
    Table 31. J&J Basic Information List
    Table 32. J&J Description and Business Overview
    Table 33. J&J Pruritus Therapeutics Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Pruritus Therapeutics Business of J&J (2019-2024)
    Table 35. J&J Recent Developments
    Table 36. Abbott Basic Information List
    Table 37. Abbott Description and Business Overview
    Table 38. Abbott Pruritus Therapeutics Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Pruritus Therapeutics Business of Abbott (2019-2024)
    Table 40. Abbott Recent Developments
    Table 41. Amgen Basic Information List
    Table 42. Amgen Description and Business Overview
    Table 43. Amgen Pruritus Therapeutics Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Pruritus Therapeutics Business of Amgen (2019-2024)
    Table 45. Amgen Recent Developments
    Table 46. LEO Pharma Basic Information List
    Table 47. LEO Pharma Description and Business Overview
    Table 48. LEO Pharma Pruritus Therapeutics Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Pruritus Therapeutics Business of LEO Pharma (2019-2024)
    Table 50. LEO Pharma Recent Developments
    Table 51. Novartis Basic Information List
    Table 52. Novartis Description and Business Overview
    Table 53. Novartis Pruritus Therapeutics Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Pruritus Therapeutics Business of Novartis (2019-2024)
    Table 55. Novartis Recent Developments
    Table 56. Bayer Basic Information List
    Table 57. Bayer Description and Business Overview
    Table 58. Bayer Pruritus Therapeutics Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Pruritus Therapeutics Business of Bayer (2019-2024)
    Table 60. Bayer Recent Developments
    Table 61. Pfizer Basic Information List
    Table 62. Pfizer Description and Business Overview
    Table 63. Pfizer Pruritus Therapeutics Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Pruritus Therapeutics Business of Pfizer (2019-2024)
    Table 65. Pfizer Recent Developments
    Table 66. UCB Pharma Basic Information List
    Table 67. UCB Pharma Description and Business Overview
    Table 68. UCB Pharma Pruritus Therapeutics Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Pruritus Therapeutics Business of UCB Pharma (2019-2024)
    Table 70. UCB Pharma Recent Developments
    Table 71. GlaxoSmithKline Basic Information List
    Table 72. GlaxoSmithKline Description and Business Overview
    Table 73. GlaxoSmithKline Pruritus Therapeutics Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Pruritus Therapeutics Business of GlaxoSmithKline (2019-2024)
    Table 75. GlaxoSmithKline Recent Developments
    Table 76. Galderma Basic Information List
    Table 77. Galderma Description and Business Overview
    Table 78. Galderma Pruritus Therapeutics Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Pruritus Therapeutics Business of Galderma (2019-2024)
    Table 80. Galderma Recent Developments
    Table 81. Huapont Basic Information List
    Table 82. Huapont Description and Business Overview
    Table 83. Huapont Pruritus Therapeutics Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Pruritus Therapeutics Business of Huapont (2019-2024)
    Table 85. Huapont Recent Developments
    Table 86. Key Raw Materials Lists
    Table 87. Raw Materials Key Suppliers Lists
    Table 88. Pruritus Therapeutics Downstream Customers
    Table 89. Pruritus Therapeutics Distributors List
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
    Table 93. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Pruritus Therapeutics Product Picture
    Figure 2. Global Pruritus Therapeutics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 4. Pruritus Therapeutics Report Years Considered
    Figure 5. Global Pruritus Therapeutics Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Pruritus Therapeutics Revenue in 2023
    Figure 7. Pruritus Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Antihistamines Picture
    Figure 9. Corticosteroids Picture
    Figure 10. Calcineurin Inhibitors Picture
    Figure 11. Others Picture
    Figure 12. Global Pruritus Therapeutics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 13. Global Pruritus Therapeutics Sales Value Market Share by Type, 2023 & 2030
    Figure 14. Product Picture of External Use
    Figure 15. Product Picture of Oral
    Figure 16. Product Picture of Injection
    Figure 17. Global Pruritus Therapeutics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 18. Global Pruritus Therapeutics Sales Value Market Share by Application, 2023 & 2030
    Figure 19. North America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 20. North America Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 21. Europe Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 22. Europe Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 23. Asia Pacific Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 24. Asia Pacific Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 25. South America Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 26. South America Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 27. Middle East & Africa Pruritus Therapeutics Sales Value (2019-2030) & (US$ Million)
    Figure 28. Middle East & Africa Pruritus Therapeutics Sales Value by Country (%), 2023 VS 2030
    Figure 29. Key Countries/Regions Pruritus Therapeutics Sales Value (%), (2019-2030)
    Figure 30. United States Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 31. United States Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 32. United States Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 33. Europe Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 34. Europe Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 35. Europe Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 36. China Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 37. China Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 38. China Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 39. Japan Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 40. Japan Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 41. Japan Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 42. South Korea Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 43. South Korea Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 44. South Korea Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 45. Southeast Asia Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 47. Southeast Asia Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 48. India Pruritus Therapeutics Sales Value, (2019-2030) & (US$ Million)
    Figure 49. India Pruritus Therapeutics Sales Value by Type (%), 2023 VS 2030
    Figure 50. India Pruritus Therapeutics Sales Value by Application (%), 2023 VS 2030
    Figure 51. Pruritus Therapeutics Industrial Chain
    Figure 52. Pruritus Therapeutics Manufacturing Cost Structure
    Figure 53. Channels of Distribution (Direct Sales, and Distribution)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS